Mesenchymal stem cell- and extracellular vesicle-based therapies for Alzheimer’s disease: progress, advantages, and challenges

Alzheimer’s disease is a severe, highly disabling neurodegenerative disease, clinically characterized by a progressive decline in cognitive functions, and is the most common form of dementia in the elderly. For decades, the search for disease-modifying therapies has focused on the two main Alzheimer...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonçalves, Renata Guedes de Jesus, Vasques, Juliana Ferreira, da Silva-Junior, Almir Jordão, Gubert, Fernanda, Mendez-Otero, Rosalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154491/
https://www.ncbi.nlm.nih.gov/pubmed/36751774
http://dx.doi.org/10.4103/1673-5374.361546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154491/
https://www.ncbi.nlm.nih.gov/pubmed/36751774
http://dx.doi.org/10.4103/1673-5374.361546

Ejemplares similares